New Recombinant Mpox Strain Detected in England
Published 8 December 2025
Highlights
- A new recombinant strain of the mpox virus has been identified in England, combining elements of two existing clades.
- The UK Health Security Agency (UKHSA) is assessing the significance of this new strain, which emerged after a traveler returned from Asia.
- Vaccination remains the most effective protection against severe mpox, with the vaccine being 75-80% effective.
- Nearly 48,000 mpox cases have been reported globally in 2025, with the majority occurring in central Africa.
- Experts emphasize the importance of genomic surveillance to track viral evolution and prevent further spread.
-
Rewritten Article
New Recombinant Mpox Strain Detected in England
Health officials in England have identified a new recombinant strain of the mpox virus, highlighting the ongoing evolution of this infectious disease. The UK Health Security Agency (UKHSA) announced the discovery after a traveler returning from Asia tested positive for the virus. This new strain combines elements of two existing mpox clades, clade Ib and clade IIb, the latter of which was responsible for the global outbreak in 2022.
Understanding the New Strain
The emergence of this recombinant virus is not unexpected, given the circulation of both clades. Dr. Katy Sinka, head of sexually transmitted infections at UKHSA, noted that while viral evolution is normal, further analysis is crucial to understand how mpox is changing. "Getting vaccinated is a proven effective way to protect yourself against severe disease," she emphasized, urging eligible individuals to receive the mpox vaccine, which is 75-80% effective.
Global Impact and Response
The World Health Organization (WHO) has recorded nearly 48,000 confirmed mpox cases worldwide in 2025, with 201 deaths across 94 countries. The majority of cases have been reported in central Africa. The UK has implemented a vaccination program targeting high-risk groups, including those with multiple sexual partners and individuals frequenting sex-on-premises venues.
Expert Insights on Viral Evolution
Experts like Prof. Trudie Lang from the University of Oxford stress the importance of genomic surveillance to monitor the virus's evolution and transmission routes. Dr. Boghuma Titanji from Emory University warned that continued mpox circulation could lead to further viral recombination, entrenching mpox as a persistent human pathogen.
-
Scenario Analysis
The identification of a new mpox strain in England underscores the need for vigilant public health measures and ongoing genomic surveillance. If further cases of this strain emerge, understanding its transmission and severity will be crucial in assessing its potential threat compared to previous strains. The global health community must remain proactive in vaccine distribution, especially in regions with limited access, to prevent further outbreaks. As the virus continues to evolve, international collaboration will be essential to mitigate its impact and protect vulnerable populations worldwide.
Health officials in England have identified a new recombinant strain of the mpox virus, highlighting the ongoing evolution of this infectious disease. The UK Health Security Agency (UKHSA) announced the discovery after a traveler returning from Asia tested positive for the virus. This new strain combines elements of two existing mpox clades, clade Ib and clade IIb, the latter of which was responsible for the global outbreak in 2022.
Understanding the New Strain
The emergence of this recombinant virus is not unexpected, given the circulation of both clades. Dr. Katy Sinka, head of sexually transmitted infections at UKHSA, noted that while viral evolution is normal, further analysis is crucial to understand how mpox is changing. "Getting vaccinated is a proven effective way to protect yourself against severe disease," she emphasized, urging eligible individuals to receive the mpox vaccine, which is 75-80% effective.
Global Impact and Response
The World Health Organization (WHO) has recorded nearly 48,000 confirmed mpox cases worldwide in 2025, with 201 deaths across 94 countries. The majority of cases have been reported in central Africa. The UK has implemented a vaccination program targeting high-risk groups, including those with multiple sexual partners and individuals frequenting sex-on-premises venues.
Expert Insights on Viral Evolution
Experts like Prof. Trudie Lang from the University of Oxford stress the importance of genomic surveillance to monitor the virus's evolution and transmission routes. Dr. Boghuma Titanji from Emory University warned that continued mpox circulation could lead to further viral recombination, entrenching mpox as a persistent human pathogen.
What this might mean
The identification of a new mpox strain in England underscores the need for vigilant public health measures and ongoing genomic surveillance. If further cases of this strain emerge, understanding its transmission and severity will be crucial in assessing its potential threat compared to previous strains. The global health community must remain proactive in vaccine distribution, especially in regions with limited access, to prevent further outbreaks. As the virus continues to evolve, international collaboration will be essential to mitigate its impact and protect vulnerable populations worldwide.
